Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...
Health care product distributor Henry Schein has redoubled its effort to provide in-kind donations and grants to disaster-stricken areas, as well as to work with NGOs to proactively supply ...
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results